The global preclinical medical device testing services market share analysis is poised for significant growth, with projections estimating a CAGR of 5.3%, reaching USD 2,842.1 million by 2035. This surge is primarily driven by stringent regulatory requirements imposed by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) …